A New Jersey US district court judge withdrew his decision in a biopharma securities case Wednesday after lawyers complained ...

Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.